Jean-Pierre Bouiller
Membre du Comité d'Investissement chez Sofimac Régions SAS
Profil
Mr. Jean-Pierre Bouiller has a degree from Ecole Supérieure de Commerce in Clermont-Ferrand (1987).
He subsequently worked in accounting at Fiduciaire de France (Fidex) before joining Sofimac in October 1989.
Initially responsible for a portfolio of diversified investments, he was later entrusted with the management of sector-specific funds before being appointed Portfolio Manager for Sofimac in 1999 and Sofimac Croissance in 2005.
Postes actifs de Jean-Pierre Bouiller
| Sociétés | Poste | Début |
|---|---|---|
Sofimac Régions SAS
 Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Membre du Comité d'Investissement | 22/06/2010 |
Anciens postes connus de Jean-Pierre Bouiller
| Sociétés | Poste | Fin |
|---|---|---|
Imaxio SA
 Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sofimac Régions SAS
Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Finance |
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Health Technology |
